Unveiling New Horizons: Progress in the Management of Gastrointestinal and Hepatobiliary Cancer
- PMID: 37760401
- PMCID: PMC10526915
- DOI: 10.3390/cancers15184431
Unveiling New Horizons: Progress in the Management of Gastrointestinal and Hepatobiliary Cancer
Abstract
The field of gastrointestinal cancer research continues to make significant strides in understanding the complexities of these challenging diseases [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Choosing Neuroanaesthesia as a career: Marching towards new horizons.Indian J Anaesth. 2021 Jan;65(1):35-42. doi: 10.4103/ija.IJA_1531_20. Epub 2021 Jan 20. Indian J Anaesth. 2021. PMID: 33767501 Free PMC article.
-
Neutrophil-to-lymphocyte ratio predicts acute kidney injury occurrence after gastrointestinal and hepatobiliary surgery.World J Gastrointest Surg. 2020 Jul 27;12(7):326-335. doi: 10.4240/wjgs.v12.i7.326. World J Gastrointest Surg. 2020. PMID: 32821341 Free PMC article.
-
New horizons in managing older cancer survivors: complexities and opportunities.Age Ageing. 2023 Feb 1;52(2):afad008. doi: 10.1093/ageing/afad008. Age Ageing. 2023. PMID: 36735848
-
New horizons in the pathogenesis of gastrointestinal neuromuscular disease.J Pediatr Gastroenterol Nutr. 2007 Dec;45 Suppl 2:S97-102. doi: 10.1097/MPG.0b013e31812e6569. J Pediatr Gastroenterol Nutr. 2007. PMID: 18185077 Review.
-
COVID-19 and Gastrointestinal and Hepatobiliary Diseases.Pediatr Ann. 2021 Aug;50(8):e315-e319. doi: 10.3928/19382359-20210721-02. Epub 2021 Aug 1. Pediatr Ann. 2021. PMID: 34398713 Review.
Cited by
-
Employment Disruption and Financial Burden Associated with Gastrointestinal Cancers.Ann Surg Oncol. 2025 Jun 26. doi: 10.1245/s10434-025-17683-1. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40569357
References
-
- Thonhauser R., Poglitsch M., Jonas J.P., Dong Y., Tschögl M., Gramberger M., Salem M., Santol J., Brandl I., Klimpfinger M., et al. The Effect of Induction Chemotherapy with VEGF Inhibition on Tumor Response in Synchronously Metastasized Potentially Resectable Colorectal Cancer. Cancers. 2023;15:2900. doi: 10.3390/cancers15112900. - DOI - PMC - PubMed
-
- Montero-Calle A., Garranzo-Asensio M., Torrente-Rodríguez R.M., Ruiz-Valdepeñas Montiel V., Poves C., Dziaková J., Sanz R., Díaz Del Arco C., Pingarrón J.M., Fernández-Aceñero M.J., et al. p53 and p63 Proteoforms Derived from Alternative Splicing Possess Differential Seroreactivity in Colorectal Cancer with Distinct Diagnostic Ability from the Canonical Proteins. Cancers. 2023;15:2102. doi: 10.3390/cancers15072102. - DOI - PMC - PubMed
-
- Gambardella C., Mongardini F.M., Karpathiotakis M., Lucido F.S., Pizza F., Tolone S., Parisi S., Nesta G., Brusciano L., Gambardella A., et al. Biosynthetic Mesh Reconstruction after Abdominoperineal Resection for Low Rectal Cancer: Cross Relation of Surgical Healing and Oncological Outcomes: A Multicentric Observational Study. Cancers. 2023;15:2725. doi: 10.3390/cancers15102725. - DOI - PMC - PubMed
-
- Cerrito L., Ainora M.E., Borriello R., Piccirilli G., Garcovich M., Riccardi L., Pompili M., Gasbarrini A., Zocco M.A. Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives. Cancers. 2023;15:3393. doi: 10.3390/cancers15133393. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources